[FG] Khanna Gremmelmaier Nina

Kinoshita, Hannah et al. (2025) ‘T Cell Immune Response to Influenza Vaccination When Administered Prior to and Following Autologous Chimeric Antigen Receptor-Modified T Cell Therapy’, Transplantation and Cellular Therapy, 31(5), pp. 327–338. Available at: https://doi.org/10.1016/j.jtct.2025.02.019.

Frank, F.A. et al. (2025) ‘Current Concepts in Shoulder Periprosthetic Joint Infections—Are Shoulders the Same as Hips and Knees?’, Journal of Clinical Medicine, 14(8), p. 2578. Available at: https://doi.org/10.3390/jcm14082578.

Schreiber, Peter W. et al. (2025) ‘Surgical Site Infections, Risk Factors, and Outcomes After Liver Transplant’, JAMA Network Open, 8. Available at: https://doi.org/10.1001/jamanetworkopen.2025.1333.

van Delden, C. et al. (2025) ‘The Swiss Transplant Cohort Study: Implications for Transplant Infectious Diseases Research’, Transplant Infectious Disease, 27(2). Available at: https://doi.org/10.1111/tid.70023.

van den Berg, Jana et al. (2025) ‘Basic Concepts and Indications of CAR T Cells’, Hamostaseologie, 45(1), pp. 14–23. Available at: https://doi.org/10.1055/a-2491-3652.

Erdmann, Joana et al. (2025) ‘Amoxicillin Concentrations in Samples of Musculoskeletal Infections’, Helvetica Chimica Acta, 108(2). Available at: https://doi.org/10.1002/hlca.202400178.

Nyffeler, Ramon et al. (2025) ‘Fracture-related infections of the lower extremity – Analysis of costs and their drivers’, Injury, 56(2), p. 112138. Available at: https://doi.org/10.1016/j.injury.2024.112138.

Dähne, Theo et al. (2025) ‘Herpes simplex virus and drug resistance—comprehensive update on resistance mutations and implications for clinical management: a narrative review’, Clinical Microbiology and Infection [Preprint]. Available at: https://doi.org/10.1016/j.cmi.2025.04.046.

ElAbd, Hesham et al. (2025) ‘T and B cell responses against Epstein–Barr virus in primary sclerosing cholangitis’, Nature Medicine [Preprint]. Available at: https://doi.org/10.1038/s41591-025-03692-w.

Morin, Benedict (2025) Human musculoskeletal Staphylococcus aureus infections – characteristics of host-pathogen interactions and treatment failures. Doctoral Thesis. University of Basel.

Hentzien, Maxime et al. (2024) ‘Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR’HIV): a multicenter, international, non-randomized clinical trial study protocol’, BMC Infectious Diseases, 24(1). Available at: https://doi.org/10.1186/s12879-024-09192-5.

König, D. et al. (2024) ‘Adoptive cell therapy with tumor-infiltrating lymphocytes in combination with nivolumab in patients with advanced melanoma’, Immuno-Oncology and Technology, 24. Available at: https://doi.org/10.1016/j.iotech.2024.100728.

Kusejko, Katharina et al. (2024) ‘Infectious disease events in people with HIV receiving kidney transplantation: Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort Study’, BMC Infectious Diseases, 24(1). Available at: https://doi.org/10.1186/s12879-024-10026-7.

Maffei, Enea et al. (2024) ‘Phage Paride can kill dormant, antibiotic-tolerant cells of Pseudomonas aeruginosa by direct lytic replication’, Nature Communications, 15(1). Available at: https://doi.org/10.1038/s41467-023-44157-3.

Maffei, Enea et al. (2024) ‘Phage Paride can kill dormant, antibiotic-tolerant cells of Pseudomonas aeruginosa by direct lytic replication’, Nature Communications, 15(1). Available at: https://doi.org/10.1038/s41467-023-44157-3.

Bertagnolio, Silvia et al. (2024) ‘WHO global research priorities for antimicrobial resistance in human health’, The Lancet Microbe, 5(11). Available at: https://doi.org/10.1016/S2666-5247(24)00134-4.

Bausch, Severin et al. (2024) ‘Target Attainment and Population Pharmacokinetics of Cefazolin in Patients with Invasive Staphylococcus aureus Infections: A Prospective Cohort Study’, Antibiotics, 13(10), p. 928. Available at: https://doi.org/10.3390/antibiotics13100928.

Rentsch, Katharina M. et al. (2024) ‘Enhancing Stability and Investigating Target Attainment of Benzylpenicillin in Outpatient Parenteral Antimicrobial Therapy: Insights from In Vitro and In Vivo Evaluations’, Antibiotics, 13(10), p. 970. Available at: https://doi.org/10.3390/antibiotics13100970.

Vock, Isabelle et al. (2024) ‘Quantifying aminoglycoside resistance in extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales clinical isolates: a retrospective cohort study’, Swiss Medical Weekly, 154(10). Available at: https://doi.org/10.57187/s.3904.

Goede, Jeroen S. et al. (2024) ‘Rational use of immunoglobulins (IVIgs and SCIgs) in secondary antibody deficiencies’, Swiss Medical Weekly, 154(9). Available at: https://doi.org/10.57187/s.3559.

Palianina, D. et al. (2024) ‘Stem cell memory EBV-specific T cells control EBV tumor growth and persist in vivo’, Science advances, 10(34). Available at: https://doi.org/10.1126/sciadv.ado2048.

Hofer, Kevin D. et al. (2024) ‘B-cell maturation antigen-directed bispecific antibodies in plasmablastic lymphoma’, British Journal of Haematology, 205(2), pp. 722–725. Available at: https://doi.org/10.1111/bjh.19571.

Neofytos, D. and Khanna, N. (2024) ‘How I treat: Coronavirus disease 2019 in leukemic patients and hematopoietic cell transplant recipients’, Transplant Infectious Disease, 26(4). Available at: https://doi.org/10.1111/tid.14332.

Müller-Durovic, Bojana et al. (2024) ‘A metabolic dependency of EBV can be targeted to hinder B cell transformation’, Science (New York, N.Y.), 385(6704), p. eadk4898. Available at: https://doi.org/10.1126/science.adk4898.

König, David et al. (2024) ‘Melanoma Clonal Heterogeneity Leads to Secondary Resistance after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes’, Cancer Immunology Research, 12(7), pp. 814–821. Available at: https://doi.org/10.1158/2326-6066.CIR-23-0757.

De Greef, Julien et al. (2024) ‘Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation’, Journal of Infection, 88(6). Available at: https://doi.org/10.1016/j.jinf.2024.106162.

Jantarug, Krittapas et al. (2024) ‘A Far-Red Fluorescent Probe to Visualize Gram-Positive Bacteria in Patient Samples’, ACS Infectious Diseases, 10(5), pp. 1545–1551. Available at: https://doi.org/10.1021/acsinfecdis.4c00060.

Couchepin, Jade et al. (2024) ‘Isavuconazole for the Treatment of Fungal Infections: A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS)’, Open Forum Infectious Diseases, 11(5). Available at: https://doi.org/10.1093/ofid/ofae223.

Portillo, V. et al. (2024) ‘Antifungal Treatment Duration in Hematology Patients With Invasive Mold Infections: A Real-life Update’, Open Forum Infectious Diseases, 11(5). Available at: https://doi.org/10.1093/ofid/ofae201.

Salmanton-García, Jon et al. (2024) ‘Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022’, eClinicalMedicine, 71. Available at: https://doi.org/10.1016/j.eclinm.2024.102553.

Hosseini-Moghaddam, Seyed M. et al. (2024) ‘Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients: A multicenter cohort, 2015-2020’, American Journal of Transplantation, 24(4), pp. 653–668. Available at: https://doi.org/10.1016/j.ajt.2023.11.003.

Ragozzino, Silvio et al. (2024) ‘Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation: a longitudinal retrospective multicenter study’, Bone Marrow Transplantation, 59(2), pp. 278–281. Available at: https://doi.org/10.1038/s41409-023-02157-3.

Søgaard, Kirstine K. et al. (2024) ‘Evaluation of the clinical relevance of the Biofire© FilmArray pneumonia panel among hospitalized patients’, Infection, 52(1), pp. 173–181. Available at: https://doi.org/10.1007/s15010-023-02080-1.

Forrer, Pascal et al. (2024) ‘Unveiling signaling pathways inducing MHC class II expression in neutrophils’, Frontiers in Immunology, 15. Available at: https://doi.org/10.3389/fimmu.2024.1444558.

Hentzien, M. et al. (2024) ‘External validation of the Dat’AIDS score: A risk score for predicting 5-year overall mortality in people living with HIV aged 60 years or older’, HIV Medicine, 25(1), pp. 72–82. Available at: https://doi.org/10.1111/hiv.13534.

Marais, Leonard C. et al. (2024) ‘Key aspects of soft tissue management in fracture-related infection: recommendations from an international expert group’, Archives of Orthopaedic and Trauma Surgery, 144(1), pp. 259–268. Available at: https://doi.org/10.1007/s00402-023-05073-9.

Sollier, Julie et al. (2024) ‘Revitalizing antibiotic discovery and development through in vitro modelling of in-patient conditions’, Nature Microbiology, 9(1), pp. 1–3. Available at: https://doi.org/10.1038/s41564-023-01566-w.

Agnetti, Jessica et al. (2023) ‘Identification of microorganisms by a rapid PCR panel from positive blood cultures leads to faster optimal antimicrobial therapy – a before-after study’, BMC Infectious Diseases, 23(1). Available at: https://doi.org/10.1186/s12879-023-08732-9.

Ehrenzeller S et al. (2023) ‘A qualitative study on the perception of infection prevention and control measures among healthcare workers without patient contact during the SARS-CoV-2 pandemic’, Antimicrobial Resistance and Infection Control, 12(1), p. 43. Available at: https://doi.org/10.1186/s13756-023-01246-8.

Arendrup, M.C. et al. (2023) ‘European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM Candida III study’, Journal of Infection, 87(5), pp. 428–437. Available at: https://doi.org/10.1016/j.jinf.2023.08.001.

Palianina, D. et al. (2023) ‘A method for polyclonal antigen-specific T cell-targeted genome editing (TarGET) for adoptive cell transfer applications’, Molecular Therapy Methods and Clinical Development, 30, pp. 147–160. Available at: https://doi.org/10.1016/j.omtm.2023.06.007.

Baur, Katharina et al. (2023) ‘CD4+ CAR T-cell expansion is associated with response and therapy related toxicities in patients with B-cell lymphomas’, Bone Marrow Transplantation, 58(9), pp. 1048–1050. Available at: https://doi.org/10.1038/s41409-023-02016-1.

Baur, Katharina et al. (2023) ‘CD4+ CAR T-cell expansion is associated with response and therapy related toxicities in patients with B-cell lymphomas’, Bone Marrow Transplantation, 58(9), pp. 1048–1050. Available at: https://doi.org/10.1038/s41409-023-02016-1.

Lindsay, Julian et al. (2023) ‘Invasive fungal infections after CLAG-M/CLAG chemotherapy for acute myeloid leukemia and high-grade myeloid neoplasms’, Blood Advances, 7(13), pp. 3140–3145. Available at: https://doi.org/10.1182/bloodadvances.2022009562.

Hoenigl M et al. (2023) ‘Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study’, The Lancet Infectious Diseases, 23(6), pp. 751–761. Available at: https://doi.org/10.1016/S1473-3099(22)00872-6.

Neofytos D et al. (2023) ‘Bacteremia During the First Year After Solid Organ Transplantation: An Epidemiological Update’, Open Forum Infectious Diseases, 10(6), p. ofad247. Available at: https://doi.org/10.1093/ofid/ofad247.

Palianina, D. et al. (2023) Stem cell memory EBV-specific T cells control post-transplant lymphoproliferative disease and persist<i>in vivo</i>. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2023.05.30.542809.

Capoferri, Gioele et al. (2023) ‘Dynamics of antibody titers to SARS-CoV-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation’, Bone Marrow Transplantation, 58(5), pp. 597–599. Available at: https://doi.org/10.1038/s41409-023-01936-2.

Walti, Laura N. et al. (2023) ‘Vaccine-Preventable Infections Among Solid Organ Transplant Recipients in Switzerland’, JAMA Network Open, 6(4), p. E2310687. Available at: https://doi.org/10.1001/jamanetworkopen.2023.10687.

Bettonte S et al. (2023) ‘Management of Drug-Drug Interactions between Long-Acting Cabotegravir and Rilpivirine and Comedications with Inducing Properties: A Modeling Study’, Clinical Infectious Diseases, 76(7), pp. 1225–1236. Available at: https://doi.org/10.1093/cid/ciac901.

Escrihuela-Vidal F et al. (2023) ‘Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicentre cohort’, Clinical Microbiology and Infection, 29(4), pp. 498–505. Available at: https://doi.org/10.1016/j.cmi.2022.10.019.

Nguyen, A. et al. (2023) ‘Hot Topics 2022: die Sicht von jungen Infektiologinnen und Infektiologen’, Swiss Medical Forum ‒ Schweizerisches Medizin-Forum [Preprint]. Available at: https://doi.org/10.4414/smf.2023.09312.

Labarile, Marco et al. (2023) ‘Quantifying and Predicting Ongoing Human Immunodeficiency Virus Type 1 Transmission Dynamics in Switzerland Using a Distance-Based Clustering Approach’, Journal of Infectious Diseases, 227(4), pp. 554–564. Available at: https://doi.org/10.1093/infdis/jiac457.

Berton M et al. (2023) ‘Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals’, Clinical Pharmacokinetics, 62(2), pp. 277–295. Available at: https://doi.org/10.1007/s40262-022-01194-3.

Schaeffer Thibault et al. (2023) ‘Long-Term Follow-Up after Mycobacterium Chimaera Infection Following Cardiac Surgery: Single-Center Experience’, Journal of Clinical Medicine, 12(3). Available at: https://doi.org/10.3390/jcm12030948.

Busca A et al. (2023) ‘Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry’, Frontiers in Immunology, 14, p. 1125030. Available at: https://doi.org/10.3389/fimmu.2023.1125030.

Criscuolo M et al. (2023) ‘SARS-CoV-2 Infection In Patients With Mastocytosis: An EPICOVIDEHA Report’, Journal of Investigational Allergology and Clinical Immunology, 33(3), pp. 225–227. Available at: https://doi.org/10.18176/jiaci.0845.

Marchesi F et al. (2023) ‘COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)’, Haematologica, 108(1), pp. 22–33. Available at: https://doi.org/10.3324/haematol.2022.280847.

Ndege, R. et al. (2023) ‘Ultrasononography in managing extrapulmonary tuberculosis: a randomized, controlled, parallel, superiority, open-label trial’, Clin Infect Dis, 76(6), pp. 1013–1021. Available at: https://doi.org/10.1093/cid/ciac871.

Sava M et al. (2023) ‘Bloodstream infections in allogeneic haematopoietic cell recipients from the Swiss Transplant Cohort Study: trends of causative pathogens and resistance rates’, Bone Marrow Transplantation. Springer Nature, 58(1). Available at: https://doi.org/10.1038/s41409-022-01851-y.

von Rotz, M. et al. (2023) ‘A systematic outbreak investigation of SARS-CoV-2 transmission clusters in a tertiary academic care center’, Antimicrob Resist Infect Control, 12(1), p. 38. Available at: https://doi.org/10.1186/s13756-023-01242-y.

Walti, Carla Simone et al. (2023) ‘New Treatment Options for Refractory/Resistant CMV Infection’, Transplant International, 36. Available at: https://doi.org/10.3389/ti.2023.11785.

Chammartin F et al. (2022) ‘CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort Study’, Journal of Acquired Immune Deficiency Syndromes, 91(5), pp. 508–515. Available at: https://doi.org/10.1097/QAI.0000000000003094.

Castellanos-Rueda R et al. (2022) ‘speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing’, Nature Communications, 13(1), p. 6555. Available at: https://doi.org/10.1038/s41467-022-34141-8.

Ehrenzeller S et al. (2022) ‘A qualitative study on safety perception among healthcare workers of a tertiary academic care center during the SARS-CoV-2 pandemic’, Antimicrobial Resistance and Infection Control, 11(1), p. 30. Available at: https://doi.org/10.1186/s13756-022-01068-0.

Pham, Truong-Thanh et al. (2022) ‘Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients’, American Journal of Transplantation, 22(12), pp. 3031–3046. Available at: https://doi.org/10.1111/ajt.17184.

Sgaard, K.K. et al. (2022) ‘Helicobacter cinaedi als seltener Auslöser bei einem immunkompetenten Patienten’, Swiss Medical Forum ‒ Schweizerisches Medizin-Forum [Preprint]. Available at: https://doi.org/10.4414/smf.2022.09011.

Gürtler N et al. (2022) ‘Nosocomial human parainfluenza virus type 3 outbreak in immunocompromised patients, and possible lessons from the SARS-CoV-2 pandemic’, Journal of Hospital Infection. W.B. Saunders Ltd, 129. Available at: https://doi.org/10.1016/j.jhin.2022.07.002.

Palianina, D. et al. (2022) A method for polyclonal antigen-specific T cell-targeted genome editing (TarGET) for adoptive cell therapy applications. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2022.10.31.514542.

Weisser, Maja et al. (2022) ‘Characterization of pathogen-inactivated COVID-19 convalescent plasma and responses in transfused patients’, Transfusion, 62(10), pp. 1997–2011. Available at: https://doi.org/10.1111/trf.17083.

Blaskovich Mark A.T. et al. (2022) ‘A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections’, Science Translational Medicine, 14(662). Available at: https://doi.org/10.1126/scitranslmed.abj238.

Blaskovich, Mark A. T. et al. (2022) ‘A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections’, Science Translational Medicine, 14(662). Available at: https://doi.org/10.1126/scitranslmed.abj2381.

Blaskovich MAT et al. (2022) ‘A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections’, Science Translational Medicine, 14(662), p. eabj2381. Available at: https://doi.org/10.1126/scitranslmed.abj238.

Berton M et al. (2022) ‘Repository Describing the Anatomical, Physiological, and Biological Changes in an Obese Population to Inform Physiologically Based Pharmacokinetic Models’, Clinical Pharmacokinetics, 61(9), pp. 1251–1270. Available at: https://doi.org/10.1007/s40262-022-01132-3.

Darie, Andrei M et al. (2022) ‘Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial’, The Lancet Respiratory Medicine, 10(9), pp. 877–887. Available at: https://doi.org/10.1016/S2213-2600(22)00086-8.

Thoueille P et al. (2022) ‘Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland’, Pharmaceutics, 14(8). Available at: https://doi.org/10.3390/pharmaceutics14081588.

Walti, Carla S. et al. (2022) ‘Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients’, Current Opinion in Infectious Diseases, 35(4), pp. 302–311. Available at: https://doi.org/10.1097/QCO.0000000000000838.

Weisser, M. et al. (2022) Bloodstream infections in allogeneic haematopoietic cell recipients from the Swiss Transplant Cohort Study. Research Square Platform LLC. Available at: https://doi.org/10.21203/rs.3.rs-1828291/v1.

Callegari, Ilaria et al. (2022) ‘Potent neutralization by monoclonal human IgM against SARS-CoV-2 is impaired by class switch’, EMBO Reports, 23(7). Available at: https://doi.org/10.15252/embr.202153956.

Averbuch D et al. (2022) ‘Nocardia Infections in Hematopoietic Cell Transplant Recipients: A Multicenter International Retrospective Study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation’, Clinical Infectious Diseases, 75(1), pp. 88–97. Available at: https://doi.org/10.1093/cid/ciab866.

van den Bogaart L et al. (2022) ‘Central nervous system infections in solid organ transplant recipients: Results from the Swiss Transplant Cohort Study’, Journal of Infection, 85(1), pp. 1–7. Available at: https://doi.org/10.1016/j.jinf.2022.05.019.

Nguyen H et al. (2022) ‘Correction: Identifying and characterizing trans women in the swiss HIV cohort study as an epidemiologically distinct risk group (Clinical Infectious Diseases DOI: 10.1093/cid/ciab628)’, Clinical Infectious Diseases. Oxford University Press, 74(12). Available at: https://doi.org/10.1093/cid/ciac242.

Tepekule Burcu et al. (2022) ‘Impact of Latent Tuberculosis on Diabetes’, Journal of Infectious Diseases, 225(12), pp. 2229–2234. Available at: https://doi.org/10.1093/infdis/jiac054.

Balakrishna, Suraj et al. (2022) ‘Decreasing Incidence and Determinants of Bacterial Pneumonia in People With HIV: The Swiss HIV Cohort Study’, Journal of Infectious Diseases, 225(9), pp. 1592–1600. Available at: https://doi.org/10.1093/infdis/jiab573.

Peter, Jelissa Katharina et al. (2022) ‘SARS-CoV-2 Vaccine Alpha and Delta Variant Breakthrough Infections Are Rare and Mild but Can Happen Relatively Early after Vaccination’, Microorganisms, 10(5). Available at: https://doi.org/10.3390/microorganisms10050857.

Nguyen H et al. (2022) ‘Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group’, Clinical Infectious Diseases, 74(8), pp. 1468–1475. Available at: https://doi.org/10.1093/cid/ciab628.

Busca A et al. (2022) ‘COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP’, Blood Advances, 6(7), pp. 2427–2433. Available at: https://doi.org/10.1182/bloodadvances.2021005616.

Cardoso E et al. (2022) ‘Is sleep disordered breathing a risk factor for COVID-19 or vice versa?’, ERJ Open Research, 8(2). Available at: https://doi.org/10.1183/23120541.00034-2022.

Salina, Anna et al. (2022) ‘Multiplex bacterial PCR in the bronchoalveolar lavage fluid of non-intubated patients with suspected pulmonary infection: a quasi-experimental study’, ERJ Open Research, 8(2). Available at: https://doi.org/10.1183/23120541.00595-2021.

Stader F et al. (2022) ‘Physiologically Based Pharmacokinetic Modelling to Investigate the Impact of the Cytokine Storm on CYP3A Drug Pharmacokinetics in COVID-19 Patients’, Clinical Pharmacology and Therapeutics, 111(3), pp. 579–584. Available at: https://doi.org/10.1002/cpt.2402.

Jakeman B et al. (2022) ‘Anticholinergic medication use in elderly people living with HIV and self-reported neurocognitive impairment: A prospective cohort study’, Journal of Antimicrobial Chemotherapy, 77(2), pp. 492–499. Available at: https://doi.org/10.1093/jac/dkab386.

Ragozzino S et al. (2022) ‘Distribution of Aspergillus Species and Prevalence of Azole Resistance in Respiratory Samples from Swiss Tertiary Care Hospitals’, Open Forum Infectious Diseases, 9(2), p. ofab638. Available at: https://doi.org/10.1093/ofid/ofab638.

Scherrer AU et al. (2022) ‘Cohort Profile Update: The Swiss HIV Cohort Study (SHCS)’, International Journal of Epidemiology, 51(1), pp. 33–34J. Available at: https://doi.org/10.1093/ije/dyab141.

Bock, Lukas et al. (2022) ‘Air temperature and incidence of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae’, Environmental Research, 215(Pt 2), p. 114146. Available at: https://doi.org/10.1016/j.envres.2022.114146.

Bruningk, Sarah C. et al. (2022) ‘Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area’, Virus Evolution, 8(1), p. veac002. Available at: https://doi.org/10.1093/ve/veac002.

Carere-Sigl, Anja et al. (2022) ‘FimH antagonists prevent biofilm formation on catheter surfaces’, Carbohydrate Chemistry, 45, pp. 519–536. Available at: https://doi.org/10.1039/9781839164538-00519.

Jahn K et al. (2022) ‘Exercise capacity impairment after COVID-19 pneumonia is mainly caused by deconditioning’, European Respiratory Journal. European Respiratory Society, 59(1). Available at: https://doi.org/10.1183/13993003.01136-2021.

Kampouri, Eleftheria et al. (2022) ‘Managing hypogammaglobulinemia in patients treated with CAR-T-cell therapy: key points for clinicians’, Expert Review of Hematology, 15(4), pp. 305–320. Available at: https://doi.org/10.1080/17474086.2022.2063833.

Kusejko, K. et al. (2022) ‘Similar but different: integrated phylogenetic analysis of Austrian and Swiss HIV-1 sequences reveal differences in transmission patterns of the local HIV-1 epidemics’, J Acquir Immune Defic Syndr, 90(4), pp. e4–e12. Available at: https://doi.org/10.1097/qai.0000000000002949.

Kvarda, Peter et al. (2022) ‘Perioperative myocardial injury and mortality after revision surgery for orthopaedic device-related infection’, The Bone & Joint Journal, 104-B(6), pp. 696–702. Available at: https://doi.org/10.1302/0301-620x.104b6.bjj-2021-1486.r1.